Prorata, sure, none of us like to see our SP eroded. Can't stand it.
The Coy rep that replied to me said they were working very hard to increase profile and gave numerous examples, which I was satisfied with.
You have to remember, this is a biotech conducting clinical trials. You can't 'force' results, we just have to wait until results of the trials come in. To be fair, the last news item was only 10 days ago.
There is nothing in the story that has changed the outlook. Even RGS is subject to market sentiment. Even the likes of CBA have lost about 26% of SP in 6 months.
For a TA point of view, looks like a classic double bottom. Will be interesting if we get a strong rebound from here.
RGS Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
